Innovative Products, Quality Solutions

Exclusively Foot and Ankle

Products Contact

Par·a·gon (noun)


An ideal instance; a perfect embodiment of a concept. A model or pattern of excellence or perfection.

Twen·ty·eight (noun)


The second perfect number. The number of bones in the human foot including the sesamoid bones.

Welcome to commitment to foot and ankle. Welcome to Paragon 28.

Paragon 28 was established in 2010 to address unmet and under-served needs of the foot and ankle community. We are dedicated to creating tailored solutions and tools to improve the treatment of even the most difficult foot and ankle conditions. Paragon 28 operates under the following principles: inclusion and respect of individual surgeon’s preferences, creative innovation, high-quality, cost-effective implants, and a strong belief that through research and innovation, we can create new and improved solutions to the challenges faced by foot and ankle specialists.

Foot and ankle surgeons are our primary focus at Paragon 28. We listen to your ideas, your criticisms, and what needs to be better. We seek to understand your hesitance and frustrations with certain procedures and focus on how we can make things easier. The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.

Get to know us


The key to innovation is reinventing the space in which we work, rather than filling that space with more products.


Currently we have spent:









Developing innovative solutions for the foot and ankle surgeon.


Surgeries Supported


Patents Filed

V92™ Cellular Bone Matrix

V92™ Cellular Bone Matrix is a viable allogeneic bone scaffold comprised of two components: mesenchymal stem cells that are osteogenic and a blend of microparticulate cortical, cancellous and demineralized cortical allograft bone.

Key Features:

  • Sub-population of MSCs called marrow-isolated adult multilineage-inducible (MIAMI) cells are harvested and isolated from the bone marrow for V92™, providing high expansion capacity
  • Processed with a novel cryoprotectant free of exogenous proteins and DMSO
  • 92% cell viability post-thaw
  • Supplies 150,000 viable cells per cc for implantation
  • Provides osteoconductive, osteoinductive and osteogenic elements to support innate healing
See Product